ProCE Banner Activity

My Experiences Managing Pneumonitis and Hypophysitis in Patients Receiving Checkpoint Inhibitor Therapy

Clinical Thought
Using 2 real-world clinical scenarios, this commentary focuses on practical strategies to manage pulmonary and endocrine adverse events associated with checkpoint inhibition in melanoma.

Released: September 26, 2016

Expiration: September 25, 2017

No longer available for credit.

Share

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Merck Oncology